Dietrich A. Stephan, Ph.D.
CEO, Board of Directors, GP LifeX Capital
Dr. Dietrich Stephan, Ph.D., is a renowned geneticist and entrepreneur, recognized for his early leadership the field of Precision Medicine. Profiled twice on the front page of the Wall Street Journal for his seminal contributions to mankind, Stephan’s solutions are improving lives across the globe.
Dr. Diego Miralles, M.D.
Board of Directors, LifeX Labs
Dr. Miralles played a key role turning AIDS into a chronic disease, developing two of the earliest and most effective therapies. He went on to lead the drug development arm of Johnson & Johnson and is the CEO of Vivideon Therapeutics. Most recently, Miralles served as President of Adaptive Therapeutics.
Rob A. Rutenbar, Ph.D.
Board of Directors, LifeX Labs
Dr. Rob A. Rutenbar, Ph.D., is a computer scientist/engineer and entrepreneur. He led a research group at Carnegie Mellon University (CMU) and served as Head of Computer Science at the University of Illinois at Urbana-Champaign. Rutenbar is now the Senior Vice Chancellor for Research at the University of Pittsburgh, leading the entire billion-dollar research portfolio.
Rebecca O. Bagley
Corporate Secretary, LifeX Labs
Ms. Rebecca Bagley is a seasoned investment banker and economic development leader. She’s the Vice Chancellor for Economic Partnerships of the University of Pittsburgh. Bagley was President and CEO of NorTech and prior to that led the State of Pennsylvania’s investments, deploying in excess of a billion dollars.
Lindsey M. Snyder, Ph.D.
Vice President of Therapeutics, Co-Director, Biopharmaceutical Active Management Group; Treasurer, LifeX Labs
Dr. Lindsey Snyder, Ph.D., is part of the LifeX active management group, ensuring effective product development and corporate operations. Snyder’s background is in neuroscience and worked with investment groups including Blue Tree Angels as well as in operating multiple companies in the health sector including LifeX Portfolio companies, FarmaceuticalRx and Elastogenesis.
Colleen M. Cassidy, Ph.D.
Co-Director, Biopharmaceutical Active Management Group
Dr. Colleen Cassidy, Ph.D., is a neuroscientist and electrophysiologist with expertise in sensory biology, chronic pain, and addiction as well as early stage startup development. Her research provided unprecedented detail about the organization of the peripheral nervous system and is published in top-tier scientific journals. She also works with prominent angel investment groups identifying and evaluating high quality life sciences companies
Mara McFadden, M.B.A.
VP of Product and Medical Devices
Mara McFadden, MBA, is an industry executive with deep experience in medical devices and consumer technology companies. A mechanical engineer, Mara has developed, commercialized, and driven market growth for giants such as Johnson & Johnson and Philips Healthcare, as well as early-stage companies.
Director, Business Development, LifeX Labs
Kimberly Bogesdorfer is an experienced business development and corporate sales engagement executive. She has worked with several sports teams and entertainment venues in Pittsburgh, including the Pittsburgh Penguins, for several years. These roles included support in sponsorships, events, retention, promotions, entitlements, advertising and marketing. She also is a board member of the American Cancer Society of Western PA. Prior to LifeX, Kimberly's most recent work was with The Pittsburgh Technology Council.
Drew Morris, M.B.A.
GP LifeX Capital
Drew Morris, M.B.A, is an experienced early stage venture investor and active contributor to the startup ecosystem. Prior to joining LifeX, Drew was the Executive Director of BlueTree Allied Angels, a top 20 angel investment group, where he managed deal flow and was an integral part of the investment committee. Previously, he was an engineer at GE, designing next generation sensors and intelligent control systems.
Director of Operational Excellence
Ms. Magazine leads our organizations’s culture of excellence.
Her roles include heading the company’s operations. Her expertise comes from running operations at Nextel and at PNA Innovations. In addition, she also leads Human Resources, where she strives to unlock the potential of every team member to achieve unprecedented performance.
Vice President, Marketing and Communications
Wes Conard leads strategic communications and marketing for LifeX. He has held similar positions at Affymetrix as Senior Director of Public Relations and Marketing Communications, Ion Torrent as Director of Public Relations and Marketing Communications and, and Head of Marketing and Communications at 4Catalyzer. His career started as a reporter for Bloomberg and the Philadelphia Inquirer. His expertise is in communicating biotechnology innovations to the marketplace.
INVESTORS IN OUR PORTFOLIO AND TEAMS
Wilson Sonsini Goodrich & Rosati
WSGR has offices in the LifeX Labs, with legal experts regularly on site to support LifeX Portfolio companies. The range of services also includes issue stock and support financings, intellectual property protection, strategics and talent networks.
Havas Life Manchester
Developing brands through a distinctive visual style and voice. Havas Life Manchester creates bespoke branded materials and provides tailor-made marketing support.